AYN — Global Testing Balance Sheet
0.000.00%
- SG$39.69m
- SG$7.72m
- $46.39m
Annual balance sheet for Global Testing, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.7 | 17.8 | 20 | 20.3 | 25 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10.3 | 8.56 | 8.21 | 10.5 | 10.3 |
| Total Current Assets | 22 | 26.3 | 28.2 | 30.9 | 35.2 |
| Net Property, Plant And Equipment | 24.3 | 25.9 | 26.4 | 26.6 | 28.1 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 48.8 | 54.1 | 56.2 | 58.9 | 64.6 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.2 | 9.7 | 10.8 | 10.4 | 13.2 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 10.3 | 9.75 | 11 | 10.6 | 13.3 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 38.5 | 44.4 | 45.2 | 48.3 | 51.3 |
| Total Liabilities & Shareholders' Equity | 48.8 | 54.1 | 56.2 | 58.9 | 64.6 |
| Total Common Shares Outstanding |